Glycemic Control and Anti-osteopathic Effect of Propolis in Diabetic Rats

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2012 Jan 19

PMID 22253535

Citations 15

Authors

M Al-Hariri

T Gamal Eldin

B Abu-Hozaifa

A Elnour

Affiliations

Soon will be listed here.

Abstract

The aim of the study was to explore the possibility that propolis can control diabetes mellitus and prevent diabetic osteopathy in rats. The study compared 60 streptozotocin (STZ)-induced diabetic rats, with ten nondiabetic rats used as a negative control. The experimental design comprised seven groups (n = 10 rats per group): (1) nondiabetic, used as a negative control; (2) nontreated, used as a positive control; (3) treated with insulin alone; (4) treated with a single dose of propolis alone; (5) treated with a double dose of propolis; (6) treated with insulin and a single dose of propolis; and (7) treated with insulin and a double dose of propolis. After 6 weeks of treatment, the rats were sacrificed. Ratios of femur ash to femur weight and of femur weight to body weight (FW/BW) were calculated and calcium (Ca), phosphorus (P), and magnesium (Mg) concentrations in femur ash were estimated and analyzed. Fasting blood glucose (FBG), plasma insulin and glucagon, serum thiobarbituric acid reactive substances (TBARS), plasma parathyroid hormone (PTH), and calcitonin levels were also estimated and analyzed. There was significant reduction in FBG in all diabetic treated rats. Similarly, higher plasma insulin levels were observed in diabetic rats treated with propolis and insulin than in nontreated diabetic rats, although plasma insulin was not comparatively higher in diabetic rats treated with insulin alone. Serum TBARS was significantly lower in the propolis treated rats than the diabetic nontreated rats. No differences in PTH and calcitonin levels were observed among treatment groups. The FW/BW ratio was significantly higher in diabetic treated groups than in control groups. Furthermore, diabetic rats treated with propolis and insulin had significantly higher Ca, P, and Mg concentrations in femoral ash than nontreated diabetic rats and diabetic rats treated with insulin alone. In conclusion, propolis has a remarkable effect on glucose homeostasis and bone mineralization.

Citing Articles

Applications of honeybee-derived products in bone tissue engineering.

Korani S, Khalesi N, Korani M, Jamialahmadi T, Sahebkar A Bone Rep. 2024; 20:101740.

PMID: 38304620 PMC: 10831168. DOI: 10.1016/j.bonr.2024.101740.

Synthetic Calcium-Phosphate Materials for Bone Grafting.

Mishchenko O, Yanovska A, Kosinov O, Maksymov D, Moskalenko R, Ramanavicius A Polymers (Basel). 2023; 15(18).

PMID: 37765676 PMC: 10536599. DOI: 10.3390/polym15183822.

Effect of propolis on mood, quality of life, and metabolic profiles in subjects with metabolic syndrome: a randomized clinical trial.

Sajjadi S, Bagherniya M, Soleimani D, Siavash M, Askari G Sci Rep. 2023; 13(1):4452.

PMID: 36932147 PMC: 10022550. DOI: 10.1038/s41598-023-31254-y.

Synergistic Effects of Nigella sativa and Exercise on Diabetic Profiles: A Systematic Review.

Alyami H, Al-Hariri M Diabetes Ther. 2023; 14(3):467-478.

PMID: 36645572 PMC: 9841958. DOI: 10.1007/s13300-022-01362-5.

Effects of Bee Propolis on FBG, HbA1c, and Insulin Resistance in Healthy Volunteers.

Alassaf F, Jasim M, Alfahad M, Qazzaz M, Abed M, Thanoon I Turk J Pharm Sci. 2021; 18(4):405-409.

PMID: 34496480 PMC: 8430402. DOI: 10.4274/tjps.galenos.2020.50024.

References

Zimmet P, McCarty D, de Courten M . The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complications. 1997; 11(2):60-8. DOI: 10.1016/s1056-8727(96)00090-6. View

Findlay J, Dillard R . Appropriate calibration curve fitting in ligand binding assays. AAPS J. 2007; 9(2):E260-7. PMC: 2751416. DOI: 10.1208/aapsj0902029. View

Okutan H, Ozcelik N, Yilmaz H, Uz E . Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin Biochem. 2005; 38(2):191-6. DOI: 10.1016/j.clinbiochem.2004.10.003. View

Pileggi R, Antony K, Johnson K, Zuo J, Holliday L . Propolis inhibits osteoclast maturation. Dent Traumatol. 2009; 25(6):584-588. DOI: 10.1111/j.1600-9657.2009.00821.x. View

Giugliano D, Ceriello A, Paolisso G . Oxidative stress and diabetic vascular complications. Diabetes Care. 1996; 19(3):257-67. DOI: 10.2337/diacare.19.3.257. View

Ceolotto G, Gallo A, Miola M, Sartori M, Trevisan R, Del Prato S . Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes. 1999; 48(6):1316-22. DOI: 10.2337/diabetes.48.6.1316. View

Hunt J, Smith C, Wolff S . Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes. 1990; 39(11):1420-4. DOI: 10.2337/diab.39.11.1420. View

Halliwell B, Gutteridge J . Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet. 1984; 1(8391):1396-7. DOI: 10.1016/s0140-6736(84)91886-5. View

Matsui T, Ebuchi S, Fujise T, Abesundara K, Doi S, Yamada H . Strong antihyperglycemic effects of water-soluble fraction of Brazilian propolis and its bioactive constituent, 3,4,5-tri-O-caffeoylquinic acid. Biol Pharm Bull. 2004; 27(11):1797-803. DOI: 10.1248/bpb.27.1797. View

10.

Armstrong D, Browne R . The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol. 1994; 366:43-58. DOI: 10.1007/978-1-4615-1833-4_4. View

11.

McCord J, Fridovich I . Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969; 244(22):6049-55. View

12.

Thulesen J, Orskov C, Holst J, Poulsen S . Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats. Endocrinology. 1997; 138(1):62-8. DOI: 10.1210/endo.138.1.4827. View

13.

Botolin S, Faugere M, Malluche H, Orth M, Meyer R, McCabe L . Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology. 2005; 146(8):3622-31. PMC: 1242186. DOI: 10.1210/en.2004-1677. View

14.

Thrailkill K, Lumpkin Jr C, Bunn R, Kemp S, Fowlkes J . Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab. 2005; 289(5):E735-45. PMC: 2387001. DOI: 10.1152/ajpendo.00159.2005. View

15.

Fitzpatrick L . Secondary causes of osteoporosis. Mayo Clin Proc. 2002; 77(5):453-68. DOI: 10.4065/77.5.453. View

16.

Matsushige K, Basnet P, Hase K, Kadota S, Tanaka K, Namba T . Propolis protects pancreatic β-cells against the toxicity of streptozotocin (STZ). Phytomedicine. 2012; 3(2):203-9. DOI: 10.1016/S0944-7113(96)80037-7. View

17.

Bachrach L . Dual energy X-ray absorptiometry (DEXA) measurements of bone density and body composition: promise and pitfalls. J Pediatr Endocrinol Metab. 2000; 13 Suppl 2:983-8. View

18.

Thomas D, Maher F, Rogers S, Best J . Expression and regulation by insulin of GLUT 3 in UMR 106-01, a clonal rat osteosarcoma cell line. Biochem Biophys Res Commun. 1996; 218(3):789-93. DOI: 10.1006/bbrc.1996.0140. View

19.

Ha J, Choi H, Lee Y, Lee Z, Kim H . Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos. Int Immunopharmacol. 2009; 9(6):774-80. DOI: 10.1016/j.intimp.2009.03.001. View

20.

Lee E, Uhm K, Lee Y, Han M, Lee M, Park J . CAPE (caffeic acid phenethyl ester) stimulates glucose uptake through AMPK (AMP-activated protein kinase) activation in skeletal muscle cells. Biochem Biophys Res Commun. 2007; 361(4):854-8. DOI: 10.1016/j.bbrc.2007.07.068. View